INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma

Blumenthal, D; Mellinghoff, IK; van den Bent, MJ; Touat, M; Peters, K; Clarke, J; Mendez, J; Welsh, L; Mason, W; Hottinger, AF; Sanchez, JMS; Wick, W; Soffietti, R; Tron, A; Zhao, D; Pandya, S; Steelman, L; Hassan, I; Wen, P; Cloughesy, T

ANNALS OF ONCOLOGY, 2023; 34 (): S391

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索